We are a group of biostatisticians who have an interest in survival analysis, and especially cancer patient survival. We develop statistical methods, and collaborate closely with clinicians and epidemiologists to answer important research questions using appropriate methodology.
We work mainly in the area of relative survival, a framework where cancer patient survival is estimated without requiring cause of death information. Within this framework we also develop novel methods for estimating metrics with more intuitive interpretation compared to traditional measures such as the life expectancy and loss in life expectancy for cancer patients. The data we use is primarily register-based, and we have extensive experience in cancer registry data from different countries. A large part of our work focuses on comparing cancer prognosis between different population groups and across countries.